Why the study?
Oral cancer has a rising incidence worldwide, and the function of the ubiquitin E3 ligase encoded by STUB1 in its pathogenesis remained to be examined.
Does overexpression of STUB1 reduce cancer aggressiveness in oral cancer cells?
Does overexpression of STUB1 reduce cancer aggressiveness in oral cancer cells?
STUB1 acts as a tumor suppressor in oral cancer cells by downregulating TGM2, highlighting a potential therapeutic target.
Answers are grounded in this paper and cite their sources.
Should not yet change oral cancer practice; leaves open STUB1-TGM2 axis for human validation.
BACKGROUND/PURPOSE: Oral cancer is amongst the most prevalent cancers worldwide with rising incidence. Various attempts have been made to elucidate its pathogenesis, and we sought to examine the function of a ubiquitin E3 ligase that was encoded by STUB1. METHODS: The mRNA expression of STUB1 in oral cancer samples and normal counterparts was determined by qRT-PCR. Numerous assays to assess the features of cancer cells, including self-renewal capacity, invasion and migration abilities were conducted following knockdown or overexpression of STUB1. RESULTS: The expression level of STUB1 was reduced in oral cancer, which was associated with a reduced relapse-free survival. Two oral cancer cell lines with low expression of STUB1 (SAS and HSC3) were chosen for the overexpression of STUB1. We showed that ectopic expression of STUB1 led to the downregulation of TGM2, a multifunctional protein that contributed to cancer progression in several cancers. Our results demonstrated that overexpression of STUB1 suppressed the cancer aggressiveness, while restoration of TGM2 reverted the effects. Last, we showed that STUB1 silencing resulted in enhanced cancer features. CONCLUSION: The abnormal downregulation of STUB1 may lessen its suppressive effect on TGM2, which induced the onset or exacerbated the progression of oral cancer. The therapeutic approach to enhance the expression of STUB1 could be a promising direction for cancer therapy.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: